Microtubule-based motility plays an important role in vesicular trafficking in hepatocyte. A critical motor for this process is hepatocyte cytoplasmic dynein. Activation of dynein could be a critical event in the initiation of transport of specific vesicles or in the control of the speed of transport. Virtually nothing is known about how cytoplasmic dynein becomes active in any cell. Using in vitro assays, this project will explore whether the molecular basis of dynein activation can be demonstrated to involve cAMP-dependent phosphorylation of cytoplasmic dynein heavy or light chains. The proposal is modelled after our current understanding of the activation of axonemal dynein by cAMP-dependent phosphorylation of a 29kDa regulatory light chain. Cytoplasmic dynein will be obtained from cultured rat hepatocyte and characterized biochemically, structurally by negative stain electron microscopy and functionally by in vitro microtubule translocation assays. Conditions will be explored whereby cytoplasmic dynein may be phosphorylated in a cAMP-dependent manner in permeabilized hepatocyte or in cell homogenates. It is not yet known whether any cytoplasmic microtubule motor is regulated by 2nd messenger dependent phosphorylation. If such conditions can be found, the phosphorylated dynein will be prepared for comparison to non-phosphorylated controls. Phosphorylation could increase microtubule translocation rate. If this is so, the project will be extended to define the molecular basis of this increase, more specifically to explore whether a light chain corresponding to that of axonemal dynein is present in cytoplasmic dynein and whether its cAMP-dependent phosphorylation controls translocation rate and the speed of vesicular trafficking.

Project Start
1997-06-01
Project End
1998-05-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Caballero, Benjamin; Wang, Yipeng; Diaz, Antonio et al. (2018) Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell 17:
Akiyama, Matthew J; Agyemang, Linda; Arnsten, Julia H et al. (2018) Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis 18:74
Willis, Ian M (2018) Maf1 phenotypes and cell physiology. Biochim Biophys Acta Gene Regul Mech 1861:330-337
Wang, Tony Y; Portincasa, Piero; Liu, Min et al. (2018) Mouse models of gallstone disease. Curr Opin Gastroenterol 34:59-70
Hodge, Dayle Q; Cui, Jihong; Gamble, Matthew J et al. (2018) Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition. Sci Rep 8:841
Sharma, Yogeshwar; Liu, Jinghua; Kristian, Kathleen E et al. (2018) In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation with Bone Marrowderived Myofibroblasts or Inflammatory Cells and not Hepatocytes is Deleterious. Gene Expr :
Stepankova, Martina; Bartonkova, Iveta; Jiskrova, Eva et al. (2018) Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor. Mol Pharmacol 93:631-644
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Liu, Zhongbo; Apontes, Pasha; Fomenko, Ekaterina V et al. (2018) Mangiferin Accelerates Glycolysis and Enhances Mitochondrial Bioenergetics. Int J Mol Sci 19:

Showing the most recent 10 out of 451 publications